
14
Aesculap
®
MINOP inVent trocar 30°
Validated reprocessing procedure
General safety instructions
Note
Adhere to national statutory regulations, national and
international standards and directives, and local, clini-
cal hygiene instructions for sterile processing.
Note
For patients with Creutzfeldt-Jakob disease (CJD), sus-
pected CJD or possible variants of CJD, observe the rel-
evant national regulations concerning the reprocessing
of products.
Note
Mechanical reprocessing should be favored over man-
ual cleaning as it gives better and more reliable results.
Note
Successful processing of this medical device can only
be ensured if the processing method is first validated.
The operator/sterile processing technician is responsi-
ble for this.
The recommended chemistry was used for validation.
Note
If there is no final sterilization, then a virucidal disin-
fectant must be used.
Note
For the latest information on reprocessing and material
compatibility see also the Aesculap extranet at
www.aesculap-extra.net
The validated steam sterilization procedure was carried
out in the Aesculap sterile container system.
General information
Dried or affixed surgical residues can make cleaning
more difficult or ineffective and lead to corrosion.
Therefore the time interval between application and
processing should not exceed 6 h; also, neither fixating
pre-cleaning temperatures >45 °C nor fixating disin-
fecting agents (active ingredient: aldehydes/alcohols)
should be used.
Excessive measures of neutralizing agents or basic
cleaners may result in a chemical attack and/or to fad-
ing and the laser marking becoming unreadable visu-
ally or by machine for stainless steel.
Residues containing chlorine or chlorides e.g. in surgi-
cal residues, medicines, saline solutions and in the ser-
vice water used for cleaning, disinfection and steriliza-
tion will cause corrosion damage (pitting, stress
corrosion) and result in the destruction of stainless
steel products. These must be removed by rinsing thor-
oughly with demineralized water and then drying.
Additional drying, if necessary.
Only process chemicals that have been tested and
approved (e.g. VAH or FDA approval or CE mark) and
which are compatible with the product’s materials
according to the chemical manufacturers’ recommen-
dations may be used for processing the product. All the
chemical manufacturer's application specifications
must be strictly observed. Failure to do so can result in
the following problems:
■
Optical changes of materials, e.g. fading or discol-
oration of titanium or aluminum. For aluminum,
the application/process solution only needs to be
of pH >8 to cause visible surface changes.
■
Material damage such as corrosion, cracks, fractur-
ing, premature aging or swelling.
Summary of Contents for Aescualp MINOP inVent trocar 30
Page 2: ......
Page 3: ...11 10 1 4 3 2 9 8 7 5 6...
Page 165: ...163 MINOP inVent 30...
Page 167: ...165 5 MINOP inVent 1 2 6 5 3 MINOP inVent 1 2 3 5 3 4 5 6 3 1 5 1 5 1...
Page 168: ...166 Aesculap MINOP inVent 30 5 5 6 7 6 5 1 5 1...
Page 169: ...167 7 3 5 MINOP inVent 1 8 8 5 1 5 3 1...
Page 170: ...168 Aesculap MINOP inVent 30 7 MINOP inVent 1 9 9 3 8 MINOP inVent 1 10 10 7 8 1 8 3 1...
Page 171: ...169 3 5 MINOP inVent 1 11 11 4 12 12 7 1 3 1 4...
Page 173: ...171 15 5 8 6 9 5 8 3 7 12 16 16 1 9 3 8 7...
Page 174: ...172 Aesculap MINOP inVent 30 10 11 17 17 11 2 18 18 11 10 11 2...
Page 175: ...173 10 11 19 MINOP inVent 1 19 4 20 20 11 1 9 4...
Page 176: ...174 Aesculap MINOP inVent 30 Aesculap Extranet www aesculap extra net Aesculap 6 45 C...
Page 177: ...175 VAH FDA CE pH 8 www a k i org Rote Brosch re 6...
Page 178: ...176 Aesculap MINOP inVent 30 H2O2 55 C...
Page 179: ...177 TA013543 20...
Page 180: ...178 Aesculap MINOP inVent 30 FDA CE BBraun Stabimed T C F t I 15 2 pH 9 II 1...
Page 181: ...179 I 35 15 1 5 II...
Page 183: ...181 Aesculap Aesculap STERILIT I lspray JG600 STERILIT I Tropf ler JG598...
Page 185: ...183 FH620R MINOP 30 inVent PE204A 30 MINOP RT068R MINOP inVent...